ReviewThe Korean journal of helicobacter and upper gastrointestinal research2026
Artificial Intelligence for Esophageal Precancerous Lesions and Esophageal Cancer.
Review in The Korean journal of helicobacter and upper gastrointestinal research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Esophageal cancer is associated with a relatively poor prognosis. Early detection and diagnosis are important for the survival and prognosis of patients with esophageal cancer. Recently, the development of artificial intelligence (AI) and its application in clinical medicine has led to remarkable progress in various endoscopic fields, including the detection of Barrett's esophagus and esophageal cancer. Compared to human errors induced by fatigue and impairment in diagnostic precision, progression in the field of AI, including deep learning and convolutional neural networks, has resulted in improved diagnostic accuracy. Subtle microvascular changes in lesions, visual disturbances, and fatigue, as well as varying endoscopic expertise depending on the operator, are the major causes of missing rates in detecting cancerous lesions. Specifically, the rate of missed diagnoses of esophageal squamous cell carcinoma reaches 4%-17%. In contrast, deep learning-based AI assists in the diagnosis of esophageal squamous cell carcinoma, evaluation of invasion depth, microvascular classification, and delineation of the margin of the lesion. In this review article, we investigated the development of the current AI model introduced for esophageal precancerous lesions, including Barrett's and esophageal cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.